Skip to main content

News Archive

News Archive - All Stories

Geisel Library Exhibit Sheds Light on Chinese Workers Who Built Transcontinental Railway

January 13, 2016

The Chinese and the Iron Road: Building the Transcontinental, produced by the Chinese Historical Society of America and the Chinese Railroad Workers Project at Stanford University, is on display through February 29, 2016 in Geisel Library on the University of California, San Diego campus.

Neurosurgeons Evaluate Precision Laser Treatment Of Brain Tumors at UC San Diego Health

January 13, 2016

Neurosurgeons at UC San Diego Health have initiated a landmark, multi-center study to evaluate how the treatment of brain tumors using the NeuroBlate system, a minimally invasive, FDA-approved laser device, impacts the quality of life of patients.

Vaccine Targets Alzheimer’s Disease-like Characteristics in People with Down Syndrome

January 13, 2016

In the first clinical trial of its type, researchers at University of California, San Diego School of Medicine and the Alzheimer’s Disease Cooperative Study (ADCS), in collaboration with AC Immune, a biotechnology company based in Switzerland, will test the safety and tolerability of an immunotherapy vaccine that targets Alzheimer’s disease-like characteristics in adults with Down syndrome.

First Human In Vitro Model of Rare Neurodegenerative Condition Created

January 13, 2016

Researchers at University of California, San Diego School of Medicine and Rady Children’s Hospital-San Diego have created the first stem cell-derived in vitro cellular model of a rare, but devastating, neurodegenerative condition called Cockayne syndrome (CS).

Brain monitoring takes a leap out of the lab

January 12, 2016

Bioengineers and cognitive scientists have developed the first portable, 64-channel wearable brain activity monitoring system that’s comparable to state-of-the-art equipment found in research laboratories. The system is a better fit for real-world applications because it is equipped with dry EEG sensors that are easier to apply than wet sensors, while still providing high-density brain activity data.

UC San Diego Receives Record 84,198 Freshman and 18,480 Transfer Applications for Fall 2016

January 11, 2016

The University of California, San Diego has received a record total of 102,678 freshman and transfer applications for fall 2016. The university had the second highest number of applicants among the University of California campuses.

UC San Diego Health and Sharp HealthCare Announce Joint Liver Transplantation Program

January 11, 2016

UC San Diego Health and Sharp HealthCare have formed a joint program to enhance liver transplantation service¬¬s in San Diego by combining resources, collaborating on research and expanding specialized liver care. The alliance is expected to strengthen clinical services for patients with end-stage liver disease while reducing costs.

Invitation to UC San Diego Faculty, Students for Digitally-Mediated Performances, Presentations

January 8, 2016

The Qualcomm Institute's Initiative for Digital Exploration of Arts and Sciences (IDEAS) is inviting proposals from UC San Diego artists and technologists to stage digitally-mediated performances or presentations during the 2016-17 season.

New UC San Diego Visual Arts Major Emphasizes Designing for the Future

January 7, 2016

Like the campus to which it belongs, the UC San Diego Department of Visual Arts blends art, science and emerging technologies. Accordingly, with an eye on the future and an emphasis on students’ marketable skills, the department offers a unique approach to design with a new undergraduate major called, “speculative design.” The first courses, already with wait-lists, are underway during Winter Quarter 2016.

UC San Diego Skaggs School of Pharmacy and Janssen R&D Collaborate to Treat Chagas Disease

January 7, 2016

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego have entered into a research collaboration with Janssen Research & Development, LLC (Janssen R&D), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to identify new therapeutic targets for Chagas disease, a parasitic infection that is the leading cause of heart failure in Latin America.
Category navigation with Social links